Green Cross Vaccine to construct new high tech vaccine plant.

Published: 2005-05-20 06:57:00

Updated: 2005-05-20 06:57:00

Green Cross Vaccine's new plant has been completed at Shingal, Gyeonggido on May 17 for the production of B hepatitis viral vaccine and pediatric combined vaccines with a double time of its production capacity (400 vials/min.), about 100 million dose per year, than the current vaccine production....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK